Bruce Liu leads Simon-Kucher’s Life Sciences division in Greater China. He has over 20 years of experience in the life sciences industry and is recognized as a thought leader on key industry topics, with recent publications on medtech access trends, reimbursement listing outlooks, business model innovations, and globalization strategy.
Shiyi He is a consultant with extensive experience in health economics and payer strategies in China.
Ivy Jiang is a consultant with years of experience in China pharmaceutical pricing and access strategies.
Duo Xu is a consultant specialized in China pharma and healthcare industry with recent experience on NRDL renewals.
Selene Peng is a consultant with experience across diverse therapeutic areas, and recent experience on NRDL trends and outlook.